Anupendra Sharma

Anupendra Sharma is the Global VP of Growth & Business Development at Siemens Healthineers within Enterprise Services & Solutions and the Founder of the Startup Leadership Program. Previously, he was Senior Investment Partner at Siemens Venture Capital. Anupendra served on the Board of USARAD, Seventh Sense, China Diagnostics (acquired by Actis & Orbimed), Sequenom (NASD: SQNM), BioImagene (acquired by Roche) and Cylex (acquired by Viracor-IBT), and served on the boards of Novira Therapeutics (Acquired by Johnson & Johnson) and Reflectance Medical (acquired by Zoll). Prior to Siemens Venture Capital, Anupendra worked in M&A at JPMorgan, Salomon Smith Barney and Siemens. Anupendra also worked in strategy consulting for McKinsey, and Product Development Finance for Ford, where he was a member of the core team that set-up Ford in China and India. Anupendra founded the Startup Leadership Program, which has educated 2,500 entrepreneurs in 28 cities in 13 countries who have started more than 1,000 companies that have raised $550 million. 53 startups have been acquired. He also co-created and teaches the Healthcare Innovation & Commercialization course at Harvard Medical School that has educated 700 MDs, PhDs, Postdocs and faculty. Anupendra was Founder & Chairman of Mobile Medics Healthcare, named the Most Outstanding Social Venture of the Year at the Global Social Venture Competition in 2006, with an idea to bring inexpensive healthcare to rural India. Mobile Medics was the subject of a Japan Broadcasting documentary and several case studies. It was taken over by the Piramal Group and became the seed for eSwasthya which runs in hundreds of villages. Anupendra also co-founded the Center for Entrepreneurial Leadership at BITS Pilani, named one of India's top five entrepreneurship centers in India. Anupendra holds an MBA from Cornell, Masters in Accounting & Finance from Manchester Business School, and Masters in Economics and Bachelors of Instrumentation Engineering from BITS Pilani.